OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 76 filers reported holding OLEMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,828,279 | +64.2% | 9,135,893 | +20.0% | 3.04% | +58.8% |
| Q2 2023 | $68,731,872 | +160.2% | 7,611,503 | 0.0% | 1.92% | +98.5% |
| Q1 2023 | $26,411,915 | +41.6% | 7,611,503 | 0.0% | 0.96% | +22.6% |
| Q4 2022 | $18,648,182 | -11.2% | 7,611,503 | 0.0% | 0.79% | -9.3% |
| Q3 2022 | $21,008,000 | -32.2% | 7,611,503 | 0.0% | 0.87% | -42.0% |
| Q2 2022 | $30,979,000 | -1.9% | 7,611,503 | +2.7% | 1.50% | +18.4% |
| Q1 2022 | $31,573,000 | -54.5% | 7,411,503 | 0.0% | 1.26% | -49.8% |
| Q4 2021 | $69,372,000 | -62.2% | 7,411,503 | +11.3% | 2.52% | -64.8% |
| Q3 2021 | $183,591,000 | -1.5% | 6,661,503 | 0.0% | 7.16% | +2.5% |
| Q2 2021 | $186,389,000 | -15.7% | 6,661,503 | 0.0% | 6.99% | -15.7% |
| Q1 2021 | $221,029,000 | -31.0% | 6,661,503 | 0.0% | 8.29% | -34.2% |
| Q4 2020 | $320,285,000 | – | 6,661,503 | – | 12.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |